A French cohort study confirmed high risks for lymphoma and small bowel cancer in patients with celiac disease but also found elevated risks for pancreatic, esophageal, gastric and colonic cancers, as ...
Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The ...